Spero Therapeutics, Inc. Uncategorized Contracts & Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Interim Period Agreement, dated January 10, 2025, between the Company and Ms. Rajavelu
Spero Therapeutics, Inc.
Biotechnology
2025
Interim Period Agreement, dated January 10, 2025, between the Company and Mr. Shukla
Spero Therapeutics, Inc.
Biotechnology
2025
Amendment 3 to Exclusive License Agreement, dated March 4, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
Spero Therapeutics, Inc.
Biotechnology
2024
Employment Agreement, dated October 31, 2023, by and between the Registrant and Esther Rajavelu
Spero Therapeutics, Inc.
Biotechnology
MA
2024
Description of Registrants Securities
Spero Therapeutics, Inc.
Biotechnology
DE
2022
Description of Registrants Securities
Spero Therapeutics, Inc.
Biotechnology
DE
2020
Letter Agreement, dated June 24, 2015, by and between the Registrant and John Tomayko, M.D
Spero Therapeutics, Inc.
Biotechnology
2017